Title | B-Cell Disorders and Curcumin. |
Publication Type | Journal Article |
Year of Publication | 2017 |
Authors | Golombick T, Diamond TH, Manoharan A, Ramakrishna R |
Journal | Integr Cancer Ther |
Volume | 16 |
Issue | 3 |
Pagination | 255-257 |
Date Published | 2017 09 |
ISSN | 1552-695X |
Keywords | B-Lymphocytes, Curcuma, Curcumin, Disease Progression, Hematologic Diseases, Humans |
Abstract | Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, derived from the spice turmeric, may lead to prolonged survival and delay in progressive disease in some of these patients. |
DOI | 10.1177/1534735415622013 |
Alternate Journal | Integr Cancer Ther |
PubMed ID | 26674787 |
PubMed Central ID | PMC5759937 |